The tumor suppressor kinase LKB1: Lessons from mouse models

Journal of Molecular Cell Biology

Volumn 3, Issue 6, 2011, Pages 330-340

  Ollila, Saara ^a   Mäkelä, Tomi P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

AMPK; LKB1; mouse model; tumor suppressor

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ANTIBODY SPECIFICITY; DISEASE MODEL; EMBRYO DEVELOPMENT; ENZYMOLOGY; EPITHELIUM; GENE TARGETING; GENETICS; HOMEOSTASIS; HUMAN; MESODERM; METABOLISM; MOUSE; NEOPLASM; PEUTZ JEGHERS SYNDROME; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL;

ANIMALS; DISEASE MODELS, ANIMAL; EMBRYONIC DEVELOPMENT; EPITHELIUM; GENE TARGETING; HOMEOSTASIS; HUMANS; MESODERM; MICE; NEOPLASMS; ORGAN SPECIFICITY; PEUTZ-JEGHERS SYNDROME; PROTEIN-SERINE-THREONINE KINASES; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS;

EID: 83455245205     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjr016     Document Type: Review

References (103)

1. Alexander, A., Cai, S.L., Kim, J., et al. (2010). ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl Acad. Sci. USA 107, 4153-4158.
2. Alvarado-Kristensson, M., Rodriguez, M.J., Silio, V., et al. (2009). SADB phosphorylation of gamma-tubulin regulates centrosome duplication. Nat. Cell Biol. 11, 1081-1092.
3. Baas, A.F., Kuipers, J., van der Wel, N.N., et al. (2004). Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116, 457-466.
4. Bardeesy, N., Sinha, M., Hezel, A.F., et al. (2002). Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419, 162-167.
5. Barnes, A.P., Lilley, B.N., Pan, Y.A., et al. (2007). LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell 129, 549-563.
6. Beppu, H., Mwizerwa, O.N., Beppu, Y., et al. (2008). Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene 27, 1063-1070.
7. Bhowmick, N.A., Chytil, A., Plieth, D., et al. (2004). TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851.
8. Bruxvoort, K.J., Charbonneau, H.M., Giambernardi, T.A., et al. (2007). Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Res. 67, 2490-2496.
9. Cao, Y., Li, H., Liu, H., et al. (2010). The serine/threonine kinase LKB1 controls thymocyte survival through regulation of AMPK activation and Bcl-XL expression. Cell Res. 20, 99-108.
10. Contreras, C.M., Gurumurthy, S., Haynie, J.M., et al. (2008). Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. Cancer Res. 68, 759-766.
11. Contreras, C.M., Akbay, E.A., Gallardo, T.D., et al. (2010). Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy. Dis. Model. Mech. 3, 181-193.
12. Corradetti, M.N., Inoki, K., Bardeesy, N., et al. (2004). Regulation of the TSC pathway by LKB1: Evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18, 1533-1538.
13. Drewes, G., Ebneth, A., Preuss, U., et al. (1997). MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89, 297-308.
14. Esteller, M., Avizienyte, E., Corn, P.G., et al. (2000). Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19, 164-168.
15. Forster, L.F., Defres, S., Goudie, D.R., et al. (2000). An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers. J. Clin. Pathol. 53, 791-793.
16. Fu, A., Ng, A.C., Depatie, C., et al. (2009). Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice. Cell Metab. 10, 285-295.
17. Gan, B., Hu, J., Jiang, S., et al. (2010). Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468, 701-704.
18. Gao, B., Sun, Y., Zhang, J., et al. (2010). Spectrum of LKB1, EGFR, and KRAS mutations in Chinese lung adenocarcinomas. J. Thorac. Oncol. 5, 1130-1135.
19. Giardiello, F.M., and Trimbath, J.D. (2006). Peutz-Jeghers syndrome and management recommendations. Clin. Gastroenterol. Hepatol. 4, 408-415.
20. Giardiello, F.M., Brensinger, J.D., Tersmette, A.C., et al. (2000). Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119, 1447-1453.
21. Granot, Z., Swisa, A., Magenheim, J., et al. (2009). LKB1 regulates pancreatic beta cell size, polarity, and function. Cell Metab. 10, 296-308.
22. Guertin, D.A., and Sabatini, D.M. (2007). Defining the role of mTOR in cancer. Cancer Cell 12, 9-22.
23. Gurumurthy, S., Hezel, A.F., Sahin, E., et al. (2008). LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis. Cancer Res. 68, 55-63.
24. Gurumurthy, S., Xie, S.Z., Alagesan, B., et al. (2010). The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468, 659-663.
25. Hardie, D.G., Scott, J.W., Pan, D.A., et al. (2003). Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546, 113-120.
26. Hearle, N., Schumacher, V., Menko, F.H., et al. (2006). Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin. Cancer Res. 12, 3209-3215.
27. Hemminki, A., Markie, D., Tomlinson, I., et al. (1998). A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391, 184-187.
28. Hezel, A.F., and Bardeesy, N. (2008). LKB1; linking cell structure and tumor suppression. Oncogene 27, 6908-6919.
29. Hezel, A.F., Gurumurthy, S., Granot, Z., et al. (2008). Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol. Cell. Biol. 28, 2414-2425.
30. Huang, X., Wullschleger, S., Shpiro, N., et al. (2008). Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem. J. 412, 211-221.
31. Ikeda, Y., Sato, K., Pimentel, D.R., et al. (2009). Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction. J. Biol. Chem. 284, 35839-35849.
32. Jenne, D.E., Reimann, H., Nezu, J., et al. (1998). Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 18, 38-43.
33. Jessen, N., Koh, H.J., Folmes, C.D., et al. (2010). Ablation of LKB1 in the heart leads to energy deprivation and impaired cardiac function. Biochim. Biophys. Acta 1802, 593-600.
34. Ji, H., Ramsey, M.R., Hayes, D.N., et al. (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807-810.
35. Jishage, K., Nezu, J., Kawase, Y., et al. (2002). Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc. Natl Acad. Sci. USA 99, 8903-8908.
36. Katajisto, P., Vallenius, T., Vaahtomeri, K., et al. (2007). The LKB1 tumor suppressor kinase in human disease. Biochim. Biophys. Acta 1775, 63-75.
37. Katajisto, P., Vaahtomeri, K., Ekman, N., et al. (2008). LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nat. Genet. 40, 455-459.
38. Kemphues, K.J., Priess, J.R., Morton, D.G., et al. (1988). Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell 52, 311-320.
39. Kim, B.G., Li, C., Qiao, W., et al. (2006). Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441, 1015-1019.
40. Kishi, M., Pan, Y.A., Crump, J.G., et al. (2005). Mammalian SAD kinases are required for neuronal polarization. Science 307, 929-932.
41. Koh, H.J., Arnolds, D.E., Fujii, N., et al. (2006). Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol. Cell. Biol. 26, 8217-8227.
42. Koh, H.J., Toyoda, T., Fujii, N., et al. (2010). Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. Proc. Natl Acad. Sci. USA 107, 15541-15546.
43. Koivunen, J.P., Kim, J., Lee, J., et al. (2008). Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br. J. Cancer 99, 245-252.
44. Londesborough, A., Vaahtomeri, K., Tiainen, M., et al. (2008). LKB1 in endothelial cells is required for angiogenesis and TGFbeta-mediated vascular smooth muscle cell recruitment. Development 135, 2331-2338.
45. Lu, K.H., Wu, W., Dave, B., et al. (2008). Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin. Cancer Res. 14, 2543-2550.
46. Martin, S.G., and St Johnston, D. (2003). A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature 421, 379-384.
47. Matsumoto, S., Iwakawa, R., Takahashi, K., et al. (2007). Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26, 5911-5918.
48. McCarthy, A., Lord, C.J., Savage, K., et al. (2009). Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation. J. Pathol. 219, 306-316.
49. Mehenni, H., Lin-Marq, N., Buchet-Poyau, K., et al. (2005). LKB1 interacts with and phosphorylates PTEN: A functional link between two proteins involved in cancer predisposing syndromes. Hum. Mol. Genet. 14, 2209-2219.
50. Mehenni, H., Resta, N., Park, J.G., et al. (2006). Cancer risks in LKB1 germline mutation carriers. Gut 55, 984-990.
51. Miyaki, M., Iijima, T., Hosono, K., et al. (2000). Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome. Cancer Res. 60, 6311-6313.
52. Miyoshi, H., Nakau, M., Ishikawa, T.O., et al. (2002). Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res. 62, 2261-2266.
53. Miyoshi, H., Deguchi, A., Nakau, M., et al. (2009). Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+/2 mice. Cancer Sci. 100, 2046-2053.
54. Morton, J.P., Jamieson, N.B., Karim, S.A., et al. (2010). LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest. Gastroenterology 139, 586-597.
55. Nakada, D., Saunders, T.L., and Morrison, S.J. (2010). Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468, 653-658.
56. Nakau, M., Miyoshi, H., Seldin, M.F., et al. (2002). Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res. 62, 4549-4553.
57. Ohashi, K., Ouchi, N., Higuchi, A., et al. (2010). LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis. J. Biol. Chem. 285, 22291-22298.
58. Partanen, J.I., Nieminen, A.I., Mäkelä, T.P., et al. (2007). Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc. Natl Acad. Sci. USA 104, 14694-14699.
59. Pearson, H.B., McCarthy, A., Collins, C.M., et al. (2008). Lkb1 deficiency causes prostate neoplasia in the mouse. Cancer Res. 68, 2223-2232.
60. Pietras, K., and Ostman, A. (2010). Hallmarks of cancer: Interactions with the tumor stroma. Exp. Cell Res. 316, 1324-1331.
61. Robinson, J., Nye, E., Stamp, G., et al. (2008). Osteogenic tumours in Lkb1-deficient mice. Exp. Mol. Pathol. 85, 223-226.
62. Rossi, D.J., Ylikorkala, A., Korsisaari, N., et al. (2002). Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc. Natl Acad. Sci. USA 99, 12327-12332.
63. Sahin, F., Maitra, A., Argani, P., et al. (2003). Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod. Pathol. 16, 686-691.
64. Sakamoto, K., McCarthy, A., Smith, D., et al. (2005). Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 24, 1810-1820.
65. Sakamoto, K., Zarrinpashneh, E., Budas, G.R., et al. (2006). Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am. J. Physiol. Endocrinol. Metab. 290, E780-E788.
66. Sanchez-Cespedes, M., Parrella, P., Esteller, M., et al. (2002). Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 62, 3659-3662.
67. Sato, N., Rosty, C., Jansen, M., et al. (2001). STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am. J. Pathol. 159, 2017-2022.
68. Shackelford, D.B., and Shaw, R.J. (2009). The LKB1-AMPK pathway: Metabolism and growth control in tumour suppression. Nat. Rev. Cancer 9, 563-575.
69. Shackelford, D.B., Vasquez, D.S., Corbeil, J., et al. (2009). mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc. Natl Acad. Sci. USA 106, 11137-11142.
70. Shaw, R.J., Bardeesy, N., Manning, B.D., et al. (2004). The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6, 91-99.
71. Shaw, R.J., Lamia, K.A., Vasquez, D., et al. (2005). The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646.
72. Shelly, M., Cancedda, L., Heilshorn, S., et al. (2007). LKB1/STRAD promotes axon initiation during neuronal polarization. Cell 129, 565-577.
73. Shen, C.Y., Yu, J.C., Lo, Y.L., et al. (2000). Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 60, 3884-3892.
74. Shorning, B.Y., Zabkiewicz, J., McCarthy, A., et al. (2009). Lkb1 deficiency alters goblet and paneth cell differentiation in the small intestine. PloS One 4, e4264.
75. Shorning, B.Y., Griffiths, D., and Clarke, A.R. (2011). Lkb1 and pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder. PloS One 6, e16209.
76. Spicer, J., Rayter, S., Young, N., et al. (2003). Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1. Oncogene 22, 4752-4756.
77. Stoothoff, W.H., and Johnson, G.V. (2005). Tau phosphorylation: Physiological and pathological consequences. Biochim. Biophys. Acta 1739, 280-297.
78. Strazisar, M., Mlakar, V., Rott, T., et al. (2009). Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma. Cancer Invest. 27, 407-416.
79. Su, G.H., Hruban, R.H., Bansal, R.K., et al. (1999). Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am. J. Pathol. 154, 1835-1840.
80. Sun, G., Tarasov, A.I., McGinty, J.A., et al. (2010a). LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo. Am. J. Physiol. Endocrinol. Metab. 298, E1261-E1273.
81. Sun, G., Tarasov, A.I., McGinty, J.A., et al. (2010b). Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo.Diabetologia 53, 924-936.
82. Sun, G., Reynolds, R., Leclerc, I., et al. (2011). RIP2-mediated LKB1 deletion causes axon degeneration in the spinal cord and hind-limb paralysis. Dis. Model. Mech. 4, 193-202.
83. Takeda, H., Miyoshi, H., Kojima, Y., et al. (2006). Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/2p532/2 compound mutant mice. Oncogene 25, 1816-1820.
84. Tamas, P., Macintyre, A., Finlay, D., et al. (2010). LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells. Eur. J. Immunol. 40, 242-253.
85. Trimboli, A.J., Cantemir-Stone, C.Z., Li, F., et al. (2009). Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461, 1084-1091.
86. Udd, L., Katajisto, P., Rossi, D.J., et al. (2004). Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. Gastroenterology 127, 1030-1037.
87. Udd, L., Katajisto, P., Kyyronen, M., et al. (2010). Impaired gastric gland differentiation in Peutz-Jeghers syndrome. Am. J. Pathol. 176, 2467-2476.
88. Vaahtomeri, K., and Mäkelä, T.P. (2011). Molecular mechanisms of tumor suppression by LKB1. FEBS Lett. 585, 944-951.
89. Vaahtomeri, K., Ventela, E., Laajanen, K., et al. (2008). Lkb1 is required for TGFbeta-mediated myofibroblast differentiation. J. Cell Sci. 121, 3531-3540.
90. Vallenius, T., Vaahtomeri, K., Kovac, B., et al. (2010). An association between NUAK2 and MRIP reveals a novel mechanism for regulation of actin stress fibers. J. Cell Sci. 124, 384-393.
91. van Lier, M.G., Wagner, A., Mathus-Vliegen, E.M., et al. (2010). High cancer risk in Peutz-Jeghers syndrome: A systematic review and surveillance recommendations. Am. J. Gastroenterol. 105, 1258-1264; author reply 1265.
92. Wang, S., Gao, J., Lei, Q., et al. (2003). Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4, 209-221.
93. Wei, C., Amos, C.I., Stephens, L.C., et al. (2005). Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. Cancer Res. 65, 11297-11303.
94. Wingo, S.N., Gallardo, T.D., Akbay, E.A., et al. (2009). Somatic LKB1 mutations promote cervical cancer progression. PloS One 4, e5137.
95. Woods, A., Heslegrave, A.J., Muckett, P.J., et al. (2011). LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice. Biochem. J. 434, 49-60.
96. Xie, Z., Dong, Y., Zhang, J., et al. (2009). Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol. Cell. Biol. 29, 3582-3596.
97. Yang, T.L., Su, Y.R., Huang, C.S., et al. (2004). High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity. Genes Chromosomes Cancer 41, 250-256.
98. Yee, N.S., Furth, E.E., and Pack, M. (2003). Clinicopathologic and molecular features of pancreatic adenocarcinoma associated with Peutz-Jeghers syndrome. Cancer Biol. Ther. 2, 38-47.
99. Ylikorkala, A., Rossi, D.J., Korsisaari, N., et al. (2001). Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 293, 1323-1326.
100. Zagorska, A., Deak, M., Campbell, D.G., et al. (2010). New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci. Signal. 3, ra25.
101. Zhou, G., Myers, R., Li, Y., et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174.
102. Zhou, J., Huang, W., Tao, R., et al. (2009). Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells. Oncogene 28, 1993-2002.
103. Zoncu, R., Efeyan, A., and Sabatini, D.M. (2011). mTOR: From growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35.